Zevra Therapeutics, Inc. ZVRA Q2 2025 earnings
Reported August 12, 2025 · After market close
Revenue$25.9MBeat by $1.4M
EPS$1.21Miss by $0.98
Revenue estimate$24.5M
EPS estimate$2.19
Next report
Aug 5, 2026 (In 1 week)Revenue estimate$33.9M
EPS estimate$0.08
Financials
Q2 2025Valuation & ratios
Segments
Versus estimates
Revenue
Diluted EPS
Ask the moment Zevra Therapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Zevra Therapeutics, Inc. report Q2 2025 earnings?
- Zevra Therapeutics, Inc. (ZVRA) reported Q2 2025 earnings on August 12, 2025 after market close.
- What were Zevra Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- Zevra Therapeutics, Inc. reported revenue of $25.9M and eps of $1.21 for Q2 2025.
- Did Zevra Therapeutics, Inc. beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $24.5M by $1.4M. EPS missed the consensus estimate of $2.19 by $0.98.
- How did Zevra Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 481.7% from $4.4M a year earlier.
- Where can I find Zevra Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001628280-25-039967) directly on SEC EDGAR. The filing index links above go to sec.gov.